Latest filing published 20 May 2022 for Enochian Biosciences Inc, €955k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Serhat Gumrukcu: trading record in brief
All filings by Serhat Gumrukcu on record concern Lunai Bioworks Inc., in the capacity of chief executive. In total, 2 filings cover trades dated 18 May 2022.
The open-market record consists of 2 sales worth €1.9M, with no purchase.
The latest filing, published on 20 May 2022, reports an open-market sale of €982k in Lunai Bioworks Inc. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Serhat Gumrukcu
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 125,000 shares@ US$8.00100.0% of flowCommon StockSEC:0001731122-22-000960:0
1 of 1 declaration